期刊文献+

高渗氯化钠羟乙基淀粉40注射液对老年患者凝血功能的影响 被引量:4

The influence of injecting hypertonic sodium chloride hydroxylethyl starch 40 on blood coagulation of old patient
下载PDF
导出
摘要 目的通过临床研究预注高渗氯化钠羟乙基淀粉40注射液(HSS40)对老年患者凝血及血小板功能的影响,探讨HSS40在老年患者的临床应用可行性。方法选择ASAⅠ~Ⅱ级,20例老年、神经外科手术患者,所有患者均采用静吸复合麻醉。入室后局麻下行桡动脉及颈内静脉穿刺,以4ml/kg输注HSS40,30分钟内输注完毕。分别在输注HSS40前、输注HSS40完毕即刻、输注后30min、60min监测:#$凝血酶原时间(PT)、纤维蛋白原(FIB)、部分凝血活酶时间(APTT);$%应用Sonoclot分析仪测定初期凝血形成时间(ACTonset)、纤维蛋白形成速率(凝血速率ClotRate)和血小板功能(PF);$&K+、Na+、Ca2+、HCT、HB等血气和血糖指标。结果与输注HSS40前相比,输注HSS40即刻APTT延长(P>0.05)、PT明显延长(P<0.05),输注毕30minAPTT、PT延长达到最高峰(P<0.05),输注毕60min逐渐恢复正常(P>0.05);输注HSS40对FIB的影响统计学上无意义(P>0.05);输注HSS40前后ACT、ClotRate、PF的改变统计学上无意义(P>0.05);K+浓度降低,统计学上无意义(P>0.05);Na+浓度升高,输注HSS40即刻改变最为明显(P<0.05),之后逐渐恢复,输注毕60min基本恢复至入室时基础值(P>0.05);Ca2+浓度没有明显改变(P>0.05);HCT、HB随着输注液体的增加逐渐降低,与入室时相比P<0.05;各时间点血糖没有明显改变(P>0.05)。结论适量输入HSS40(4ml/kg)对老年患者凝血及血小板功能和电解质、血糖无明显影响,可安全应用于临床。 Objective To evaluate the influence of hypertonic sodium chloride hydroxylethyl starch 40 (HSS40)on blood coagulation,platelet function,electrolytes and blood glucose of old patient. Methods ASA Ⅰ - Ⅱ, twenty old patients of neurosurgical procedures were observed. All received general anesthesia. Radial artery and right jugular veins were catheterized under local anesthesia in all patients. HSS40 was injections at 4ml/kg during 30min after vein catheterization. To record PT, APTT,FIB,ACT,Clot Rate,PF and K^+,Na^+,Ca^2+,HCT,HB ,blood glucose before intravenous infusing HSS40,after infusing and 30min,60min later.Results Compare with before infusing HSS40 and 60min later, APTT and PT were much higher after infusing 30min(P〈0.05 )and reeovery normal after infusing 60min. There was no significant difference on FIB ,ACT,Clot Rate and PF (P〉0.05). The altered of Na^+ was much higher at 30min (P〈0.05). There was no significant difference on K^+ and Ca^2+ and blood glucose (P〉0.05). Conclusion HSS40 is no influence on blood coagulation, platelet function,electrolytes and blood glucose, it may be valuable for clinical application.
作者 赵蔚 孙传玉
出处 《中国现代医药杂志》 2008年第6期27-30,共4页 Modern Medicine Journal of China
关键词 高渗氯化钠 羟乙基淀粉 血液凝固 血小板 SONOCLOT Hypertonic saline solution Hetastarch Blood coagulation Platelet Sonoclot
  • 引文网络
  • 相关文献

参考文献8

  • 1[2]Mei JM,Hui SC,Xiao N,et al.Effects of small-volume infusion of 7.5% hypertonic saline/6% dextran-70 on the cardiovascular function of traumatichemorrhagic shock rats at high altitude.Shock,1995,4:421
  • 2[3]Veroli P,Benhamou D.Comparison of hypertonic saline (5%),isoton ic saline and Ringer's lactate for fluid preloading before lumbar exterdural anaesthesia.Br J Anaesth,1992,69:461
  • 3[4]Scalabrini A,Simonetti P,Velasco IT,et al.Hypertonic NaC1 solution prevents Bupivacaine-induced cardiovascular toxicity.Circ Shock,1992,36(2):231
  • 4徐云,马瑞云.6%贺斯行急性等容血液稀释对凝血功能的影响[J].现代实用医学,2005,17(1):33-35. 被引量:10
  • 5[6]Martin G,Bennett-Guerrero E,Wakeling H,et al.A prospective,randomized comparison of thromboelastographic coagulation profile in patients receiving lactated Ringer's solution,6% hetastarch in a balanced-saline vehicle,or 6% hetastarch in saline during major surgery.J Cardiothorac Vase Anesth,2002,16(4):441-6.
  • 6[7]Strauss RG,Pennell BJ,Stump DC.A randomized,blinded trial comparing the hemostatic effects of pentastarch versus hetastarch.Transfusion,2002,42(1):27-36
  • 7尚游,袁世荧,姚尚龙.高渗氯化钠羟乙基淀粉溶液对失血性休克兔应激反应的影响[J].中华麻醉学杂志,2005,25(1):37-39. 被引量:5
  • 8[10]0 Atkin SL,Coady AM,White MC,et al,Hyponatraemia secondary to celebral salt wasting syndrome following routine pituitary surgery.Eur J Emdoerinol,1996,135:245-247

二级参考文献21

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2126
  • 2Mouren S, Delayance S, Mion G, et al. Mechanisms of increased myocardial contractility with hypertonic saline solutions in isolated bloodperfused rabbit hearts. Anesth Analg, 1995, 81: 777-782.
  • 3Doyle JA, Davis DP, Hoyt DB. The usc of hypertonic saline in the treatment of traumatic brain injury. J Trauma, 2001, 50: 367-383.
  • 4Cross JS, Gruber DP, Gann DS, et al. Hypertonic saline attenuates the hormonal response to injury. Ann Surg, 1989, 209: 684-691.
  • 5Yilmazlar A, Yilmazlar T, Ozcan B, et al. Vasopressin, rennin, and adrenocorticotropic hormone levels during the resuscitation of hemorrhagic shock in dogs. J Emerg Med, 2000, 18: 405-408.
  • 6Moller DE, Flier JS. Insulin resistance-mechanisms, syndromes, and implications. N Engl J Med, 1991, 325: 938-948.
  • 7Kerimeier U, Messmer K. Small-volume resuscitation: from experimental evidence to clinical routine. Advantages and disadvantages of hypertonic solutions. Acta Anaesthesiol Scand, 2002, 46: 625-638.
  • 8Vollmar B, Lang G, Menger MD, et al. Hypertonic hydroxyethyl starch restores hepatic microvascular perfusion in hemorrhagic shock. Am J Physiol, 1994, 266: H1927-H1934.
  • 9Treib J, HassA, Pindur G, et al.HES200/0.5 is not HES 200/0. 5.Influence of the c2/c6 hydroxyethylation ratio of hydroxyethyl starch(HES) on hemorheology, coagulation and elimination kinetics [ J ]. Thromb Haemost, 1995, 74 ( 6 ) : 1452 -1456.
  • 10London M J, Franks M, Verrier ED, et al. The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution . A randomized clinical trial[J]. J Thorac Cardiovasc Surg, 1992,104(2) :284 -296.

共引文献12

同被引文献64

引证文献4

二级引证文献18

;
使用帮助 返回顶部